CAMPBELL, CA — (June 18, 2018) – Saama Technologies, Inc., a leading big data and advanced analytics solutions company, today announced that Mehdi Benchoufi, M.D., Assistant Professor in the Clinical Epidemiology Center at Hôtel-Dieu Hospital, University Paris Descartes, has joined its Board of Advisors (BOA).
Dr. Benchoufi focuses on interfaces between clinical research and open technologies, with a strong focus on Blockchain. In 2017, he co-authored a compelling white paper entitled “Blockchain Technology for Improving Clinical Research Quality.” He coordinates and is co-founder of a number of Open Science programs, such as echOpen or epidemium, and was also Associate Professor in pure mathematics and a software developer.
“I am delighted to join the Board of Advisors at Saama Technologies,” said Dr. Benchoufi. “Saama’s novel approaches in data pipeline management for clinical trials and applying deep learning-driven insights to transform the planning and operational management of clinical trials intrigue me. In particular, I am keen to advise and work together with the Saama team on improving clinical research quality by leveraging Blockchain.”
Rebecca Kush, Ph.D., member of Saama’s BOA said, “We are honored to have someone of Dr. Benchoufi’s stature collaborating with us to address current clinical research challenges such as reproducibility, data sharing, personal data privacy concerns and patient enrollment.”
Sagar Anisingaraju, Chief Strategy Officer of Saama, added, “Saama welcomes Dr. Benchoufi to its Advisory Board. His pioneering work in addressing these research challenges with Blockchain technology and integrating those capabilities with the industrial strength solutions that Saama is bringing to table will hugely enhance the clinical trials landscape.”
With the addition of Dr. Benchoufi to its Board of Advisors, Saama is reinforcing its commitment to providing the Life Sciences industry with solutions that deliver impactful and actionable business outcomes.
Saama Technologies is the advanced data and analytics company delivering actionable business insights for life sciences and the Global 2000. Saama is singularly focused on driving fast, flexible, impactful business outcomes for its clients through advanced data and analytics. Saama’s unique “hybrid” approach integrates focused solutions and expertise across the life sciences domain, business consulting, machine learning, automated data management, cloud and big data technologies. Saama’s approach integrates manual and disconnected data initiatives into a well-aligned roadmap facilitating the client’s journey from strategy through solution implementation.